Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

OTHER_GOV × Uveal Melanoma × Ipilimumab × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Recruiting 1 Completed 1

Sponsor Class

OTHER 14 INDUSTRY 6 NIH 3 OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Uveal Melanoma 2 Sarcoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Melanoma 1 Gastrointestinal Stromal Tumors 1 Desmoplastic Small Round Cell Tumor 1 Chondrosarcoma 1 Bone Neoplasms 1

Interventions

Melphalan 3 Interleukin-2 3 Nivolumab 2 Ipilimumab 2 pembrolizumab 1 entinostat 1 Tramadol 1 Ibuprofen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04463368 2025-03-28

SCANDIUM II

Vastra Gotaland Region

Phase 1 Completed

Uveal Melanoma

NCT06519266 2024-11-25

SCANDIUM-III

Vastra Gotaland Region

Phase 3 Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡